The cost of a drug used to treat a rare liver disorder rose by more than 1,500 percent, according to Sanders’s office.| Articles – Truthout
By Anne Blythe In an effort to tamp down confusion and frustration about who can and can’t get a COVID vaccine, and whether they have to have a health care provider’s prescription, state health director Larry Greenblatt has issued orders making access to the new boosters easier. Anyone 65 and older can now go to […] The post People 65 and older no longer need a prescription for a COVID booster appeared first on North Carolina Health News.| North Carolina Health News
As Robert F. Kennedy Jr. reshapes federal vaccine policy and guidelines, NC physicians talk about practical effects and frustration.| North Carolina Health News
‘In addition to not being very safe, these drugs also make sleep quality worse in ways that may be detrimental to brain health.’| Sleep Review
Today's blog shares strategies for extended health coverage plans to consider as drug plan costs are projected to increase between 6% and 9%.| Word on Benefits
Compass Pathways has been aggressively using patent claims to corner the market on psychedelic-assisted treatments.| The American Prospect
On average, the new Medicare negotiated drug prices are 2.8 times the average of drug prices in 11 OECD countries of similar size and wealth.| Peterson-KFF Health System Tracker
In their ongoing quest to lower prescription drug prices, some states are forcing drugmakers to continue to sell cheaper medications to thousands of pharmacies through a federal drug-discount program.| Stateline
This chart collection explores how health spending is expected to grow in coming years. In 2024, per capita health spending growth is estimated to have slowed to 4.5%.| Peterson-KFF Health System Tracker
This analysis of survey data finds that over 40% of adults under 65 with private insurance could be indicated for a GLP-1 drug though relatively few have a claim, suggesting that a much smaller share seeks treatment through healthcare providers.| Peterson-KFF Health System Tracker
This analysis uses the Merative MarketScan 2022 commercial claims to estimate the number of enrollees in the employer-sponsored insurance market who use one or more of the ten drugs selected for Medicare Part D price negotiations.| Peterson-KFF Health System Tracker
The U.S. spends more on healthcare per capita than its peers. Most of the additional health spending goes to providers for inpatient and outpatient care.| Peterson-KFF Health System Tracker
Urban and rural communities have come to depend on pharmacies as a trusted care option and a place for advice.| AP News
An Associated Press analysis of licensing data from 44 states, data from the National Council for Prescription Drug Programs and the American Community Survey shows residents of neighborhoods that are majority Black and Latino have fewer pharmacies per capita than people who live in mostly white nei| AP News
Drugs solely approved to treat obesity have minimal to no coverage on most ACA Marketplace plans. Wegovy, a semaglutide approved for weight loss, is included in just 1% of Marketplace plans, while Ozempic, which has the same active ingredient but is approved for diabetes treatment and sometimes used off-label for weight loss, is included in 82% of Marketplace plan formularies. Among ACA Marketplace plans with these drugs on formulary, prior authorization is required by most plans. All plans ...| Peterson-KFF Health System Tracker
Although most adults are in good health and have health insurance, more than 1 in 4 adults (28%) reported delaying or foregoing healthcare due to cost.| Peterson-KFF Health System Tracker